Home > Financial Ratios > GLAXOSMITHKLINE PHARMACEUTICALS

GLAXOSMITHKLINE PHARMACEUTICALS
Net Sales Growth

    Back to All Ratios
GLAXOSMITHKLINE PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Net Sales Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Net Sales Growth(%) 8.566.21-0.8012.05-9.27

What is the latest Net Sales Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?

The latest Net Sales Growth ratio of GLAXOSMITHKLINE PHARMACEUTICALS is 8.56 based on Mar2025 Consolidated results.
Year Net Sales Growth
Mar20258.56
Mar20246.21
Mar2023-0.80
Mar202212.05
Mar2021-9.27

How is Net Sales Growth of GLAXOSMITHKLINE PHARMACEUTICALS Trending?

Years Net Sales Growth % Change
Mar2025 8.56
37.84
Mar2024 6.21
Positive
Mar2023 -0.8
Negative
Mar2022 12.05
Positive
Mar2021 -9.27 -

Other Financial Ratios of GLAXOSMITHKLINE PHARMACEUTICALS


Compare Net Sales Growth ratio of peers of GLAXOSMITHKLINE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS ₹44,045.7 Cr 0.1% 9.3% 27.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAXOSMITHKLINE PHARMACEUTICALS

0.1%

9.3%

27.4%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses